Document is current
Any future updates will be listed below
-
Authors
Rischke, Samuel
Poor, Sorwe Mojtahed
Gurke, Robert
Hahnefeld, Lisa
Köhm, Michaela
Ultsch, Alfred
Geisslinger, Gerd
Behrens, Frank
Lötsch, Jörn
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1039/Z01, DFG LO 612/16-1)
Fraunhofer-Gesellschaft (Fraunhofer Cluster of Excellence for Immune Mediated diseases CIMD, Fraunhofer Cluster of Excellence for Immune Mediated diseases CIMD)
Innovative Medicines Initiative 2 Joint Undertaking (101007757, 101007757)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 18 June 2023
Accepted: 9 December 2023
First Online: 19 December 2023
Competing interests
: The authors declare no competing interests.
